Open Payments

KARUNA KONERU

Type
Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
Where
PAOLI, IN
NPI
1336146372
Received
$1,284 in 62 records, 2019 to 2024
As principal investigator
$27,465 of research payments to others in 6 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2024General payment20$503
2023General payment31$594
2022General payment4$84
2021General payment2$30
2020General payment2$28
2019General payment3$41

By company

CompanyRecordsAmountYears
Novartis Pharmaceuticals Corporation14$2272022–2024
AstraZeneca Pharmaceuticals LP7$1412020–2023
Merck Sharp & Dohme LLC7$1322023–2024
Daiichi Sankyo Inc.1$1082024
BeiGene USA, Inc.1$972024
GENZYME CORPORATION4$912023–2024
Celgene Corporation4$722022–2023
Eisai Inc.3$622023–2024
PFIZER INC.3$502023
GlaxoSmithKline, LLC.3$422023
Regeneron Healthcare Solutions, Inc.2$362023
Exelixis Inc.2$352022–2023
E.R. Squibb & Sons, L.L.C.2$322023
Genentech USA, Inc.2$302019–2023
ABBVIE INC.1$292023
Gilead Sciences, Inc.2$272021–2023
Alexion Pharmaceuticals, Inc.1$192023
Genmab U.S., Inc.1$192024
Janssen Biotech, Inc.1$142019
Amgen Inc.1$112019

By nature of payment

NatureRecordsAmount
Food and Beverage60$1,253
Education2$30

Records

DateCompanyAmountNatureFormProductStudyYear
2024-12-05Merck Sharp & Dohme LLC$13Food and BeverageIn-kind items and servicesKEYTRUDA Biological, ONCOLOGY2024
2024-11-25Eisai Inc.$20Food and BeverageIn-kind items and servicesLenvima Drug, Oncology2024
2024-11-11Novartis Pharmaceuticals Corporation$27Food and BeverageIn-kind items and servicesSCEMBLIX Drug, Oncology2024
2024-11-11Novartis Pharmaceuticals Corporation$0Food and BeverageIn-kind items and servicesSCEMBLIX Drug, Oncology2024
2024-11-07Merck Sharp & Dohme LLC$20Food and BeverageIn-kind items and servicesKEYTRUDA Biological, ONCOLOGY2024
2024-10-21GENZYME CORPORATION$22Food and BeverageIn-kind items and servicesSARCLISA Biological, Oncology2024
2024-07-15Novartis Pharmaceuticals Corporation$30Food and BeverageIn-kind items and servicesKISQALI Drug, Oncology2024
2024-05-15Novartis Pharmaceuticals Corporation$12Food and BeverageIn-kind items and servicesKISQALI Drug, Oncology2024
2024-05-15Novartis Pharmaceuticals Corporation$0Food and BeverageIn-kind items and servicesKISQALI Drug, Oncology2024
2024-04-22Novartis Pharmaceuticals Corporation$22Food and BeverageIn-kind items and servicesMEKINIST Drug, Oncology2024
2024-03-21Novartis Pharmaceuticals Corporation$17Food and BeverageIn-kind items and servicesFabhalta Drug, Immunology2024
2024-03-12Novartis Pharmaceuticals Corporation$16Food and BeverageIn-kind items and servicesKISQALI Drug, Oncology2024
2024-03-07Merck Sharp & Dohme LLC$16Food and BeverageIn-kind items and servicesKEYTRUDA Biological, ONCOLOGY2024
2024-02-24BeiGene USA, Inc.$97Food and BeverageIn-kind items and servicesBRUKINSA Drug, Oncology2024
2024-02-15Merck Sharp & Dohme LLC$16Food and BeverageIn-kind items and servicesKEYTRUDA Biological, ONCOLOGY2024
2024-02-08Novartis Pharmaceuticals Corporation$12Food and BeverageIn-kind items and servicesSCEMBLIX Drug, Oncology2024
2024-02-08Novartis Pharmaceuticals Corporation$10Food and BeverageIn-kind items and servicesSCEMBLIX Drug, Oncology2024
2024-01-29Novartis Pharmaceuticals Corporation$17Food and BeverageIn-kind items and servicesTAFINLAR Drug, Oncology2024
2024-01-18Daiichi Sankyo Inc.$108Food and BeverageIn-kind items and servicesEnhertu Drug, ONCOLOGY2024
2024-01-15Genmab U.S., Inc.$19Food and BeverageIn-kind items and servicesEpkinly Drug, Oncology2024
2023-12-18E.R. Squibb & Sons, L.L.C.$17Food and BeverageCash or cash equivalentOPDIVO Biological, Oncology2023
2023-12-11Regeneron Healthcare Solutions, Inc.$17Food and BeverageIn-kind items and servicesLIBTAYO Biological, ONCOLOGY2023
2023-12-07Genentech USA, Inc.$14Food and BeverageIn-kind items and servicesAlecensa Biological, BioOncology2023
2023-11-30GENZYME CORPORATION$18Food and BeverageIn-kind items and servicesSARCLISA Biological, Oncology2023
2023-11-27GENZYME CORPORATION$25Food and BeverageIn-kind items and servicesJEVTANA Drug, Oncology2023
2023-11-13AstraZeneca Pharmaceuticals LP$22Food and BeverageIn-kind items and services2023
2023-11-06Gilead Sciences, Inc.$15Food and BeverageIn-kind items and services2023
2023-10-30ABBVIE INC.$29Food and BeverageIn-kind items and servicesVENCLEXTA Drug, ONCOLOGY2023
2023-10-23Novartis Pharmaceuticals Corporation$16Food and BeverageIn-kind items and servicesPIQRAY Drug, Oncology2023
2023-10-19Regeneron Healthcare Solutions, Inc.$18Food and BeverageIn-kind items and servicesLIBTAYO Biological, ONCOLOGY2023
2023-10-11Merck Sharp & Dohme LLC$22Food and BeverageIn-kind items and servicesKEYTRUDA Biological, ONCOLOGY2023
2023-10-10PFIZER INC.$20Food and BeverageIn-kind items and servicesXTANDI Drug, ONCOLOGY2023
2023-10-05Merck Sharp & Dohme LLC$19Food and BeverageIn-kind items and servicesKEYTRUDA Biological, ONCOLOGY2023
2023-09-25GlaxoSmithKline, LLC.$14Food and BeverageIn-kind items and servicesZEJULA Drug, ONCOLOGY2023
2023-09-06Celgene Corporation$13Food and BeverageCash or cash equivalentPomalyst Drug, Hematology2023
2023-08-24Merck Sharp & Dohme LLC$24Food and BeverageIn-kind items and servicesKEYTRUDA Biological, ONCOLOGY2023
2023-08-21Novartis Pharmaceuticals Corporation$18Food and BeverageIn-kind items and servicesKISQALI Drug, Oncology2023
2023-08-03Eisai Inc.$20Food and BeverageCash or cash equivalentLenvima Drug, Oncology2023
2023-06-19Alexion Pharmaceuticals, Inc.$19Food and BeverageIn-kind items and servicesULTOMIRIS Biological, Rare Disease2023
2023-06-01Celgene Corporation$23Food and BeverageCash or cash equivalentREBLOZYL Biological, Hematology2023
2023-05-31GlaxoSmithKline, LLC.$13Food and BeverageIn-kind items and servicesZEJULA Drug, ONCOLOGY2023
2023-05-19PFIZER INC.$15Food and BeverageIn-kind items and servicesINLYTA Drug, ONCOLOGY2023
2023-05-19GlaxoSmithKline, LLC.$15Food and BeverageIn-kind items and servicesZEJULA Drug, ONCOLOGY2023
2023-04-10E.R. Squibb & Sons, L.L.C.$15Food and BeverageCash or cash equivalentOPDUALAG Drug, Oncology2023
2023-03-21Eisai Inc.$21Food and BeverageCash or cash equivalentLenvima Drug, Oncology2023
2023-02-13GENZYME CORPORATION$25Food and BeverageIn-kind items and servicesJEVTANA Drug, Oncology2023
2023-02-10AstraZeneca Pharmaceuticals LP$23Food and BeverageIn-kind items and servicesLYNPARZA Drug, Oncology2023
2023-02-02Exelixis Inc.$17Food and BeverageCash or cash equivalentCABOMETYX Drug, Oncology2023
2023-01-23AstraZeneca Pharmaceuticals LP$18Food and BeverageIn-kind items and services2023
2023-01-20PFIZER INC.$14Food and BeverageIn-kind items and servicesINLYTA Drug, ONCOLOGY2023
2023-01-05Celgene Corporation$23Food and BeverageCash or cash equivalentREBLOZYL Biological, Hematology2023
2022-12-13Exelixis Inc.$18Food and BeverageCash or cash equivalentCabometyx Drug, Oncology2022
2022-12-08Celgene Corporation$12Food and BeverageCash or cash equivalentPomalyst Drug, Hematology2022
2022-11-01Novartis Pharmaceuticals Corporation$24Food and BeverageIn-kind items and servicesPROMACTA Drug, ONCOLOGY2022
2022-09-27AstraZeneca Pharmaceuticals LP$29Food and BeverageIn-kind items and servicesIMFINZI Biological, Oncology2022
2021-10-08AstraZeneca Pharmaceuticals LP$19EducationIn-kind items and services2021
2021-06-01Gilead Sciences, Inc.$11EducationIn-kind items and services2021
2020-11-04AstraZeneca Pharmaceuticals LP$12Food and BeverageIn-kind items and servicesLYNPARZA Drug, Oncology2020
2020-01-06AstraZeneca Pharmaceuticals LP$16Food and BeverageIn-kind items and services2020
2019-12-18Amgen Inc.$11Food and BeverageIn-kind items and servicesMVASI Biological, Oncology2019
2019-11-21Janssen Biotech, Inc.$14Food and BeverageIn-kind items and servicesBalversa Drug, Oncology2019
2019-07-18Genentech USA, Inc.$15Food and BeverageIn-kind items and servicesTECENTRIQ Biological, BioOncology2019

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2020-10-28Dova PharmaceuticalsINDIANA UNIVERSITY HEALTH$2,250Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of avatrombopag in subjec2020
2020-10-28Dova PharmaceuticalsINDIANA UNIVERSITY HEALTH$3,000Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of avatrombopag in subjec2020
2020-07-31Amgen Inc.INDIANA UNIVERSITY HEALTH SOUTHERN INDIANA PHYSICIANS$255Prospective Observational Study of Onpro vs SOC.2020
2020-03-20Amgen Inc.INDIANA UNIVERSITY HEALTH BLOOMINGTON INC$11,503Prospective Observational Study of Onpro vs SOC.2020
2019-12-17Dova PharmaceuticalsINDIANA UNIVERSITY HEALTH$8,750Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of avatrombopag in subjec2019
2019-08-07Amgen Inc.INDIANA UNIVERSITY HEALTH BLOOMINGTON INC$1,707Prospective Observational Study of Onpro vs SOC2019

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Orange CountyPaoli town

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Paoli, IN, county Orange County, IN, state Indiana; placed by its city name.

MeasurePlace (city or town)
Paoli, IN
County
Orange County, IN
State
Indiana
Population B010033,12519,7676,851,073
Population, 2020 census P13,66619,8676,785,528
Median age B0100242.642.738.1
Under 18 B0100123.2%22.9%23.3%
65 and over B0100131.3%20.8%16.8%
Households B110011,2877,9702,716,009
Foreign born B050021.0%1.5%6.3%
Median household income B19013$42,906$65,873$71,957
Median family income B19113$51,917$85,650$90,767
Per capita income B19301$31,494$34,262$38,351
Poverty rate B1700125.2%13.4%12.3%
Unemployment rate B230257.8%3.1%4.3%
Civilian labor force B230251,1049,6953,472,016
Mean commute (minutes) B0801324.925.324.1
Bachelor's degree or higher B1500314.0%16.1%29.5%
Housing units B250011,4809,1012,976,568
Owner-occupied B2500362.2%78.7%70.6%
Renters B2500337.8%21.3%29.4%
Median home value B25077$150,700$158,700$218,200
Median gross rent B25064$799$855$1,062
White, not Hispanic B0300286.3%93.3%75.4%
Black B030020.4%1.2%9.1%
Hispanic or Latino B030024.4%1.8%8.6%
Asian B030020.0%0.5%2.6%
American Indian and Alaska Native B030020.0%0.0%0.1%

Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); Unemployment rate: 4.2% in Sep 2016 to 3.4% in Sep 2026; low 2.9%, high 16.9% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Paoli, IN.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.